Skip to main content

Table 4 Association of principal components factors with time to all-cause mortality or all-cause hospitalization

From: Circulating long chain acylcarnitines and outcomes in diabetic heart failure: an HF-ACTION clinical trial substudy

Factor

Overall

Non-diabetic

Diabetic

Interaction p value

HR

p value

BH p value

HR

p value

BH p value

HR

p value

BH p value

Unadjusted

 1

0.964

0.325

0.407

       

 2

1.020

0.602

0.602

       

 3

1.094

0.047

0.094

       

 4

1.162

0.006

0.024

1.265

0.008

0.008

1.097

0.186

0.279

0.244

 5

0.800

5E-11

6E-10

0.864

0.004

0.006

0.629

8E-11

2E-10

2E-4

 6

1.115

0.021

0.050

       

 7

0.896

0.018

0.050

       

 8

0.884

0.004

0.024

0.783

0.001

0.003

0.943

0.283

0.283

0.039

 9

1.086

0.078

0.134

       

 10

1.042

0.373

0.407

       

 11

1.059

0.262

0.393

       

 12

1.041

0.365

0.407

       

Adjusteda

 4

0.933

0.352

0.352

0.865

0.289

0.289

0.975

0.783

0.832

0.725

 5

0.798

2.74E-8

8.22E-8

0.902

0.104

0.156

0.635

3.21E-9

9.62E-9

0.001

 8

0.939

0.213

0.320

0.814

0.028

0.084

1.01

0.832

0.832

0.012

  1. aModel is adjusted for race (white vs. non-white), sex, age, baseline left ventricular ejection fraction, creatinine, BMI, baseline peak VO2, treatment group, BUN and CPX duration
  2. P-values in bold indicate statistically significant association